Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2015 | 03-2014 | 03-2013 | |
| Operating Expenses | 951 | 957 | 961 |
| Operating Income | -951 | -957 | -961 |
| Interest Expense | 1,057 | 199 | 1 |
| Other Income | -295 | 0 | 14 |
| Pre-tax Income | -2,303 | -1,156 | -948 |
| Income Tax | -30 | -79 | -82 |
| Net Income Continuous | -2,273 | -1,077 | -866 |
| Net Income | $-2,273 | $-1,077 | $-866 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | -0.01 |
| EBITDA(a) | $-1,239 | $-949 | $-942 |